rs554513888

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002775.5(HTRA1):​c.-57C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,134,978 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 20 hom., cov: 32)
Exomes 𝑓: 0.017 ( 186 hom. )

Consequence

HTRA1
NM_002775.5 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.03

Publications

1 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.014).
BP6
Variant 10-122461596-C-A is Benign according to our data. Variant chr10-122461596-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 299042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0138 (2041/148090) while in subpopulation NFE AF = 0.0169 (1123/66366). AF 95% confidence interval is 0.0161. There are 20 homozygotes in GnomAd4. There are 951 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.-57C>A 5_prime_UTR_variant Exon 1 of 9 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.-57C>A 5_prime_UTR_variant Exon 1 of 9 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.154+2887C>A intron_variant Intron 1 of 8 ENSP00000498033.1 A0A3B3IU24
ENSG00000285955ENST00000650300.1 linkn.-213G>T upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2041
AN:
147978
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00941
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0168
Gnomad ASJ
AF:
0.0351
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.00737
Gnomad MID
AF:
0.0160
Gnomad NFE
AF:
0.0169
Gnomad OTH
AF:
0.0147
GnomAD2 exomes
AF:
0.0145
AC:
998
AN:
68984
AF XY:
0.0149
show subpopulations
Gnomad AFR exome
AF:
0.00882
Gnomad AMR exome
AF:
0.00596
Gnomad ASJ exome
AF:
0.0344
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00727
Gnomad NFE exome
AF:
0.0164
Gnomad OTH exome
AF:
0.0163
GnomAD4 exome
AF:
0.0168
AC:
16540
AN:
986888
Hom.:
186
Cov.:
13
AF XY:
0.0168
AC XY:
8294
AN XY:
493270
show subpopulations
African (AFR)
AF:
0.00877
AC:
159
AN:
18124
American (AMR)
AF:
0.00749
AC:
143
AN:
19090
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
517
AN:
14606
East Asian (EAS)
AF:
0.0000780
AC:
1
AN:
12824
South Asian (SAS)
AF:
0.0137
AC:
895
AN:
65110
European-Finnish (FIN)
AF:
0.00831
AC:
167
AN:
20094
Middle Eastern (MID)
AF:
0.0153
AC:
40
AN:
2606
European-Non Finnish (NFE)
AF:
0.0175
AC:
13978
AN:
797464
Other (OTH)
AF:
0.0173
AC:
640
AN:
36970
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
730
1459
2189
2918
3648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0138
AC:
2041
AN:
148090
Hom.:
20
Cov.:
32
AF XY:
0.0132
AC XY:
951
AN XY:
72120
show subpopulations
African (AFR)
AF:
0.00938
AC:
386
AN:
41144
American (AMR)
AF:
0.0168
AC:
250
AN:
14916
Ashkenazi Jewish (ASJ)
AF:
0.0351
AC:
119
AN:
3394
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5108
South Asian (SAS)
AF:
0.0125
AC:
60
AN:
4818
European-Finnish (FIN)
AF:
0.00737
AC:
67
AN:
9088
Middle Eastern (MID)
AF:
0.0172
AC:
5
AN:
290
European-Non Finnish (NFE)
AF:
0.0169
AC:
1123
AN:
66366
Other (OTH)
AF:
0.0146
AC:
30
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
98
196
294
392
490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0165
Hom.:
3

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Macular degeneration Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
13
DANN
Benign
0.89
PhyloP100
1.0
PromoterAI
-0.020
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs554513888; hg19: chr10-124221112; COSMIC: COSV64563903; COSMIC: COSV64563903; API